IBDEI071 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8817,1,3,0)
 ;;=3^65772
 ;;^UTILITY(U,$J,358.3,8818,0)
 ;;=68135^^32^471^10^^^^1
 ;;^UTILITY(U,$J,358.3,8818,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8818,1,2,0)
 ;;=2^Destruction,Conj Lesion
 ;;^UTILITY(U,$J,358.3,8818,1,3,0)
 ;;=3^68135
 ;;^UTILITY(U,$J,358.3,8819,0)
 ;;=65800^^32^471^11^^^^1
 ;;^UTILITY(U,$J,358.3,8819,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8819,1,2,0)
 ;;=2^Paracentesis of AC
 ;;^UTILITY(U,$J,358.3,8819,1,3,0)
 ;;=3^65800
 ;;^UTILITY(U,$J,358.3,8820,0)
 ;;=66170^^32^471^12^^^^1
 ;;^UTILITY(U,$J,358.3,8820,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8820,1,2,0)
 ;;=2^Fistulization Sclera for Glauc Trabecul
 ;;^UTILITY(U,$J,358.3,8820,1,3,0)
 ;;=3^66170
 ;;^UTILITY(U,$J,358.3,8821,0)
 ;;=67515^^32^471^13^^^^1
 ;;^UTILITY(U,$J,358.3,8821,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8821,1,2,0)
 ;;=2^Inject Tenon's Capsule
 ;;^UTILITY(U,$J,358.3,8821,1,3,0)
 ;;=3^67515
 ;;^UTILITY(U,$J,358.3,8822,0)
 ;;=66030^^32^472^15^^^^1
 ;;^UTILITY(U,$J,358.3,8822,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8822,1,2,0)
 ;;=2^Inj Treatment of Eye,Medication
 ;;^UTILITY(U,$J,358.3,8822,1,3,0)
 ;;=3^66030
 ;;^UTILITY(U,$J,358.3,8823,0)
 ;;=67028^^32^472^1^^^^1
 ;;^UTILITY(U,$J,358.3,8823,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8823,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,8823,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,8824,0)
 ;;=67500^^32^472^17^^^^1
 ;;^UTILITY(U,$J,358.3,8824,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8824,1,2,0)
 ;;=2^Retrobulbar Inj,Medication
 ;;^UTILITY(U,$J,358.3,8824,1,3,0)
 ;;=3^67500
 ;;^UTILITY(U,$J,358.3,8825,0)
 ;;=67505^^32^472^16^^^^1
 ;;^UTILITY(U,$J,358.3,8825,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8825,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,8825,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,8826,0)
 ;;=68200^^32^472^14^^^^1
 ;;^UTILITY(U,$J,358.3,8826,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8826,1,2,0)
 ;;=2^Subconjunctival Injection
 ;;^UTILITY(U,$J,358.3,8826,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,8827,0)
 ;;=96372^^32^472^12^^^^1
 ;;^UTILITY(U,$J,358.3,8827,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8827,1,2,0)
 ;;=2^SC/IM Injection
 ;;^UTILITY(U,$J,358.3,8827,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,8828,0)
 ;;=96402^^32^472^13^^^^1
 ;;^UTILITY(U,$J,358.3,8828,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8828,1,2,0)
 ;;=2^SQ/IM Anti-Neplastic Hormone Inj
 ;;^UTILITY(U,$J,358.3,8828,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,8829,0)
 ;;=C9257^^32^472^3^^^^1
 ;;^UTILITY(U,$J,358.3,8829,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8829,1,2,0)
 ;;=2^Bevacizumab 0.25mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8829,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,8830,0)
 ;;=J1094^^32^472^10^^^^1
 ;;^UTILITY(U,$J,358.3,8830,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8830,1,2,0)
 ;;=2^Dexamethasone Acetate per 1mg
 ;;^UTILITY(U,$J,358.3,8830,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,8831,0)
 ;;=J2778^^32^472^6^^^^1
 ;;^UTILITY(U,$J,358.3,8831,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8831,1,2,0)
 ;;=2^Ranibizumab per 0.1mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8831,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,8832,0)
 ;;=J3300^^32^472^8^^^^1
 ;;^UTILITY(U,$J,358.3,8832,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8832,1,2,0)
 ;;=2^Triescence per 1mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8832,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,8833,0)
 ;;=J3301^^32^472^5^^^^1
 ;;^UTILITY(U,$J,358.3,8833,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8833,1,2,0)
 ;;=2^Kenalog per 10mg
 ;;^UTILITY(U,$J,358.3,8833,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,8834,0)
 ;;=J3396^^32^472^11^^^^1
 ;;^UTILITY(U,$J,358.3,8834,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8834,1,2,0)
 ;;=2^Verteporfin/Visudyne per 0.1mg
 ;;^UTILITY(U,$J,358.3,8834,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,8835,0)
 ;;=J9035^^32^472^4^^^^1
 ;;^UTILITY(U,$J,358.3,8835,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8835,1,2,0)
 ;;=2^Bevacizumab 10mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8835,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,8836,0)
 ;;=J0178^^32^472^2^^^^1
 ;;^UTILITY(U,$J,358.3,8836,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8836,1,2,0)
 ;;=2^Aflibercept 1mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8836,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,8837,0)
 ;;=J7312^^32^472^9^^^^1
 ;;^UTILITY(U,$J,358.3,8837,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8837,1,2,0)
 ;;=2^Dexamethasone Intra Implant
 ;;^UTILITY(U,$J,358.3,8837,1,3,0)
 ;;=3^J7312
 ;;^UTILITY(U,$J,358.3,8838,0)
 ;;=J3301^^32^472^7^^^^1
 ;;^UTILITY(U,$J,358.3,8838,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8838,1,2,0)
 ;;=2^Triamcinolone Acetonide per 10mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8838,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,8839,0)
 ;;=67028^^32^473^1^^^^1
 ;;^UTILITY(U,$J,358.3,8839,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8839,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,8839,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,8840,0)
 ;;=J9035^^32^473^4^^^^1
 ;;^UTILITY(U,$J,358.3,8840,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8840,1,2,0)
 ;;=2^Bevacizumab 10mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8840,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,8841,0)
 ;;=J2778^^32^473^5^^^^1
 ;;^UTILITY(U,$J,358.3,8841,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8841,1,2,0)
 ;;=2^Ranibizumab per 0.1mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8841,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,8842,0)
 ;;=J3301^^32^473^8^^^^1
 ;;^UTILITY(U,$J,358.3,8842,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8842,1,2,0)
 ;;=2^Triamcinolone Acetonide per 10mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8842,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,8843,0)
 ;;=J0178^^32^473^2^^^^1
 ;;^UTILITY(U,$J,358.3,8843,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8843,1,2,0)
 ;;=2^Aflibercept 1mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8843,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,8844,0)
 ;;=C9257^^32^473^3^^^^1
 ;;^UTILITY(U,$J,358.3,8844,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8844,1,2,0)
 ;;=2^Bevacizumab 0.25mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8844,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,8845,0)
 ;;=J7312^^32^473^11^^^^1
 ;;^UTILITY(U,$J,358.3,8845,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8845,1,2,0)
 ;;=2^Dexamethasone Intra Implant
 ;;^UTILITY(U,$J,358.3,8845,1,3,0)
 ;;=3^J7312
 ;;^UTILITY(U,$J,358.3,8846,0)
 ;;=J3300^^32^473^6^^^^1
 ;;^UTILITY(U,$J,358.3,8846,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8846,1,2,0)
 ;;=2^Triescence per 1mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,8846,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,8847,0)
 ;;=64612^^32^473^15^^^^1
 ;;^UTILITY(U,$J,358.3,8847,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8847,1,2,0)
 ;;=2^Chemodenervation of Muscle Inj (eg,Botox)
 ;;^UTILITY(U,$J,358.3,8847,1,3,0)
 ;;=3^64612
 ;;^UTILITY(U,$J,358.3,8848,0)
 ;;=68200^^32^473^7^^^^1
 ;;^UTILITY(U,$J,358.3,8848,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8848,1,2,0)
 ;;=2^Subtenons Injection
 ;;^UTILITY(U,$J,358.3,8848,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,8849,0)
 ;;=67505^^32^473^12^^^^1
 ;;^UTILITY(U,$J,358.3,8849,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8849,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,8849,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,8850,0)
 ;;=67500^^32^473^13^^^^1
 ;;^UTILITY(U,$J,358.3,8850,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8850,1,2,0)
 ;;=2^Retrobulbar Inj,Any Medication
 ;;^UTILITY(U,$J,358.3,8850,1,3,0)
 ;;=3^67500
 ;;^UTILITY(U,$J,358.3,8851,0)
 ;;=66030^^32^473^14^^^^1
 ;;^UTILITY(U,$J,358.3,8851,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8851,1,2,0)
 ;;=2^Eye Injection,Unspec,Any Medication
 ;;^UTILITY(U,$J,358.3,8851,1,3,0)
 ;;=3^66030
 ;;^UTILITY(U,$J,358.3,8852,0)
 ;;=68200^^32^473^9^^^^1
 ;;^UTILITY(U,$J,358.3,8852,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8852,1,2,0)
 ;;=2^Subconjunctival Injection
 ;;^UTILITY(U,$J,358.3,8852,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,8853,0)
 ;;=J0588^^32^473^15^^^^1
 ;;^UTILITY(U,$J,358.3,8853,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8853,1,2,0)
 ;;=2^Xeomin 1 Unit (use w/ 64612)
 ;;^UTILITY(U,$J,358.3,8853,1,3,0)
 ;;=3^J0588
 ;;^UTILITY(U,$J,358.3,8854,0)
 ;;=J0587^^32^473^16^^^^1
 ;;^UTILITY(U,$J,358.3,8854,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8854,1,2,0)
 ;;=2^Myobloc 100 Units (use with 64612)
 ;;^UTILITY(U,$J,358.3,8854,1,3,0)
 ;;=3^J0587
 ;;^UTILITY(U,$J,358.3,8855,0)
 ;;=J0585^^32^473^17^^^^1
 ;;^UTILITY(U,$J,358.3,8855,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8855,1,2,0)
 ;;=2^Botox 1 Unit (use w/ 64612)
 ;;^UTILITY(U,$J,358.3,8855,1,3,0)
 ;;=3^J0585
 ;;^UTILITY(U,$J,358.3,8856,0)
 ;;=92134^^32^474^4^^^^1
 ;;^UTILITY(U,$J,358.3,8856,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8856,1,2,0)
 ;;=2^OCT Macula (retina)
 ;;^UTILITY(U,$J,358.3,8856,1,3,0)
 ;;=3^92134
 ;;^UTILITY(U,$J,358.3,8857,0)
 ;;=92133^^32^474^5^^^^1
 ;;^UTILITY(U,$J,358.3,8857,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8857,1,2,0)
 ;;=2^OCT RNFL (optic nerve)
 ;;^UTILITY(U,$J,358.3,8857,1,3,0)
 ;;=3^92133
 ;;^UTILITY(U,$J,358.3,8858,0)
 ;;=92132^^32^474^6^^^^1
 ;;^UTILITY(U,$J,358.3,8858,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8858,1,2,0)
 ;;=2^OCT Anterior Segment (angle)
 ;;^UTILITY(U,$J,358.3,8858,1,3,0)
 ;;=3^92132
 ;;^UTILITY(U,$J,358.3,8859,0)
 ;;=92250^^32^474^2^^^^1
 ;;^UTILITY(U,$J,358.3,8859,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8859,1,2,0)
 ;;=2^Fundus Photos
 ;;^UTILITY(U,$J,358.3,8859,1,3,0)
 ;;=3^92250
 ;;^UTILITY(U,$J,358.3,8860,0)
 ;;=92235^^32^474^3^^^^1
 ;;^UTILITY(U,$J,358.3,8860,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8860,1,2,0)
 ;;=2^Fluorescein Angiography
 ;;^UTILITY(U,$J,358.3,8860,1,3,0)
 ;;=3^92235
 ;;^UTILITY(U,$J,358.3,8861,0)
 ;;=92240^^32^474^7^^^^1
 ;;^UTILITY(U,$J,358.3,8861,1,0)
 ;;=^358.31IA^3^2
